Pharmafile Logo
Pharmafocus logo
Advanced Search

Janssen

Showing 15 posts of 276 posts found.

janssen_latest_logo_on_sign_closer

Janssen says cabotegravir/rilpivirine combo matches three-drug HIV maintenance therapy

February 24, 2016
Research and Development Janssen, ViiV

Janssen has announced 32-week data from an ongoing phase IIb study of an HIV regimen comprised of its rilpivirine and …

News

Johnson & Johnson hit by fall in 2015 sales

January 27, 2016
Research and Development, Sales and Marketing Janssen, Johnson and Johnson, financial results, revenue, sales

Full year sales at the healthcare giant Johnson & Johnson fell by 6% in 2015, to just over $70 billion, …

News
J&J image

Patients sue J&J for $800m for ‘hiding antibiotic side effects’

January 22, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Janssen, Johnson and Johnson, Levaquin, Margaret Hamburg, lawsuit, levofloxacin

Six users of Johnson & Johnson’s antibiotic Levaquin are to sue the company for up to $870 million, claiming the …

News
HIV infected cell

ViiV and Janssen to test new HIV regimen in Phase III trial

January 7, 2016
Manufacturing and Production, Medical Communications, Research and Development Edurant, HIV, Janssen, ViiV Healthcare, cabotegravir, collaboration, phase III, rilpivirine

Janssen has formalised its collaboration with ViiV Healthcare on the Phase III development and commercialisation of a two-drug regimen to …

News
Janssen image

Janssen, Enterome and Kymab in research collaborations

January 7, 2016
Research and Development Crohn's, Crohn’s disease, Enterome, Janssen, MD Anderson, alliance, antibodies, collaboration, crohn's disease, immuno-oncology, kymab, research

Several pharma companies have announced new collaborations, to research potential new drugs for Crohn’s disease, and immuno-oncology treatments for cancer. …

News
Bavarian Nordic logo

Janssen and Bavarian Nordic to collaborate on HPV vaccine

December 23, 2015
Research and Development Bavarian Nordic, HPV, Janssen, Vaccine, human papillomavirus, prime boost

Janssen has announced a new collaboration and license agreement with Bavarian Nordic to develop a vaccine for chronic Human Papillomavirus …

News

NICE publishes draft guidance on two prostate cancer treatments

December 11, 2015
Medical Communications, Research and Development, Sales and Marketing Astellas, Janssen, NICE, Xtandi, Zytiga, prostate cancer

NICE has issued final draft guidance recommending Astellas Pharma’s Xtandi (enzalutamide) in prostate cancer prior to chemotherapy, but not Janssen’s …

News
Janssen image

Janssen submits Stelara for EU approval for Crohn’s

December 9, 2015
Sales and Marketing Crohn’s disease, EMA, European Medicines Agency, Janssen, Stelara, crohn's disease, ustekinumab

Janssen today announced that it has submitted an application to the European Medicines Agency, seeking approval of Stelara in Crohn’s …

News
janssen_latest_logo_on_sign_closer

Strong cancer trial data for Janssen at ASH 2015

December 8, 2015
Research and Development Cancer, Janssen, darzalex, imbruvica, oncology

Janssen presented new cancer trial data at the 57th Annual American Society of Haematology (ASH) meeting Orlando, Florida – with …

News
mbeya_microscopy

Janssen in new collaboration to take on TB

December 3, 2015
Research and Development FIND, Janssen, antibiotic resistance, tuberculosis

Janssen has announced a new collaboration with the non-profit organisation FIND to step-up the fight against the public health threat …

News
janssen_scientists

J&J announces new partnerships in fight against HIV/AIDS

December 1, 2015
Research and Development AIDS, HIV, Janssen

Johnson &Johnson is entering four new public-private partnerships aimed at significantly reducing the burden of HIV incidence among young girls …

News
gsk_boronia_australia

GSK begins Phase III study of sirukumab in giant cell arteritis

November 26, 2015
Business Services, Research and Development, Sales and Marketing GSK, Janssen

GSK today announced it has begun a Phase III study evaluating sirukumab, a human anti-interleukin (IL)-6 monoclonal antibody, for the …

News
Janssen image

Janssen buys licence to diabetes and obesity drugs from Hanmi

November 10, 2015
Manufacturing and Production, Research and Development Janssen, diabetes, hanmi

Janssen could spend up to a billion dollars to buy for novel clinical stage biologics to treat diabetes and obesity. …

News
Stelera

Encouraging late-stage results for Stelara in Crohn’s disease

October 21, 2015
Research and Development, Sales and Marketing Crohn’s disease, Janssen, Stelera, crohn's disease, ustekinumab

Janssen is planning new regulatory submissions for Stelera after Phase III data found it improved responses and remission rates in …

News
janssen_stairs

Janssen submits EMA application for myeloma drug

September 14, 2015
Sales and Marketing Janssen, daratumumab, multiple myeloma

Janssen has submitted a new marketing authorisation application for European approval of daratumumab for the treatment of patients with relapsed …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025